Recent News

• 06.04.2025 - Minerva Surgical Launches HERizon™ Hysto-Kit, a Hysteroscopy Convenience Kit to Streamline Office-Based Procedures
• 10.17.2024 - Minerva Surgical Signs Agreement with Blackmaple Group (BMG) and WHAAPA
• 10.16.2024 - Symphion® Technology to Help Gynecologists Mitigate Nationwide Saline Shortage
• 10.16.2024 - Symphion® Technology to Help Gynecologists Mitigate Nationwide Saline Shortage
• 08.26.2024 - Minerva Surgical Introduces Fluid Deficit Readout Product for Operative Hysteroscopy
• 08.20.2024 - Minerva Surgical Appoints Darin Hammers as Chief Executive Officer and Member of the Board of Directors
• 08.16.2024 - The HERizon Disposable Hysteroscope aims to redefine industry standards.
• 12.15.2023 - Minerva Surgical, Inc. Announces Voluntary SEC Deregistration and Nasdaq Delisting
• 12.15.2023 - Minerva Surgical, Inc. Announces Voluntary SEC Deregistration and Nasdaq Delisting
• 11.13.2023 - Minerva Surgical Reports Third Quarter 2023 Financial Results

Recent Filings

• 01.04.2024 - 15-12G Securities registration termination [Section 12(g)]
• 12.26.2023 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 12.26.2023 - 25 Notification of the removal from listing and registration of matured, redeemed or retired securities
• 12.15.2023 - 8-K Current report
• 11.13.2023 - 8-K Current report
• 11.13.2023 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.02.2023 - SC 13E3/A Going private transaction by certain issuers
• 11.02.2023 - 8-K Current report
• 10.13.2023 - 8-K Current report